0001209191-14-056154.txt : 20140905 0001209191-14-056154.hdr.sgml : 20140905 20140905163233 ACCESSION NUMBER: 0001209191-14-056154 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140903 FILED AS OF DATE: 20140905 DATE AS OF CHANGE: 20140905 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 141086303 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-09-03 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2014-09-03 4 M 0 5200 11.27 A 344095 D Common Stock 2014-09-03 4 S 0 4100 92.59 D 339995 D Common Stock 2014-09-03 4 S 0 1100 93.53 D 338895 D Common Stock 300000 I Common Stock held in trust Common Stock 13286 I 401(k) Stock Option (right to buy) 11.27 2014-09-03 4 M 0 5200 0.00 D 2014-10-06 Common Stock 5200 21300 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $92.59 (range $92.31 to $93.14). Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $93.53 (range $93.32 to $93.72). Common stock held in grantor retained annuity trusts. Fully vested. Kenneth L. Horton, Attorney-In-Fact 2014-09-05